When Steve Brozak performs diligence on biotech stocks, he's always looking for an angle. Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into tomorrow's healthcare system.

ATHX it is a biopharmaceutical company engaged in the discovery/development of therapeutic product candidates designed to extend and enhance the quality of human life. Since the Trend Spotter signaled a buy on 12/17 the stock soared 194.69%.